Newsroom
News
Mercy BioAnalytics Appoints Dawn Mattoon, PhD, as Chief Operating Officer
NATICK, MA – July 11, 2022 – Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced the appointment of experienced biotechnology executive, Dawn Mattoon, PhD, as Chief Operating Officer,...
GENOMEWEB: Mercy BioAnalytics Aims to Detect Early Ovarian Cancer Using Extracellular Vesicles
Novel Assay for Early Detection of Ovarian Cancer from Mercy BioAnalytics Significantly Outperforms CA125 in New Research Presented at ASCO Annual Meeting
Mercy Halo Data Demonstrates Promise of Novel Extracellular Vesicle Biomarker-Based Approach for Early Cancer Detection Natick, MA – May 27, 2022 - Mercy BioAnalytics™, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer,...
Events
Ovarian Cancer Mid-West Focus
MERCY PRESENTING!
Minneapolis, MN
Nov. 10-11, 2022
November is Lung Cancer Awareness Month
AACR Special Conference: Precision Prevention, Early Detection, and Interception of Cancer,
MERCY ATTENDING!
Austin TX
Nov. 17-19, 2022